Skip to main content

Advertisement

Log in

An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Autoantibody tests are often ordered inappropriately. We aimed to evaluate the ordering patterns of these tests in our local health region and to develop a laboratory algorithm aimed at reducing unnecessary tests. Laboratory data including the number and sequence of tests, ordering physician specialties and results for antinuclear (ANA), extractable nuclear antigen (ENA) and anti-double stranded DNA (anti-dsDNA) antibody tests from 2007 to 2009 were evaluated. Based on this information and a clinical consensus meeting, an algorithm was developed and applied retrospectively to 1 year of inpatient laboratory data to simulate potential cost savings. We identified a large volume of these autoantibody tests performed, equating to testing costs of $862,706.72, where less than 17 % of each were positive. Repeated ANA tests were mostly ordered after a previously negative result, and 1 % of patients with negative results changed to ≥1:160 on repeat testing. Close to half of all ENA and anti-dsDNA tests that were ordered were done so simultaneously with ANA, suggesting their use as screening tests. This was done more frequently in the inpatient setting. An algorithm was developed where ENA and anti-dsDNA tests would be cancelled if ANA was negative in the same sample. ANA repeated within 1 year would be cancelled and the prior result provided. Application of the algorithm retrospectively simulated a 30 % cost savings. Repeat testing and simultaneous ordering of multiple tests contributed to the excessive ordering of autoantibody tests in our health region. Our proposed algorithm would reduce testing costs and should be accompanied by appropriate educational information for physicians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tan EM, Feltkamp TE, Smolen JS et al (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40(9):1601–1611

    Article  PubMed  CAS  Google Scholar 

  2. Tampoia M, Brescia V, Fontana A et al (2007) Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease. Arch Pathol Lab Med 131(1):112–116

    PubMed  CAS  Google Scholar 

  3. Solomon DH, Shmerling RH, Schur PH et al (1999) A computer based intervention to reduce unnecessary serologic testing. J Rheumatol 26(12):2578–2584

    PubMed  CAS  Google Scholar 

  4. Bonaguri C, Melegari A, Dall’Aglio P et al (2009) An Italian multicenter study for application of a diagnostic algorithm in autoantibody testing. Ann N Y Acad Sci 1173:124–129

    Article  PubMed  CAS  Google Scholar 

  5. Wiik A, Cervera R, Haass M et al (2006) European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. Lupus 15(7):391–396

    Article  PubMed  CAS  Google Scholar 

  6. Tozzoli R, Bizzaro N, Tonutti E et al (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117(2):316–324

    Article  PubMed  Google Scholar 

  7. Stinton LM, Fritzler MJ (2007) A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev 7(1):77–84

    Article  PubMed  CAS  Google Scholar 

  8. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 124(1):71–81

    PubMed  CAS  Google Scholar 

  9. Shojania K (2000) Rheumatology: 2. What laboratory tests are needed? CMAJ 162(8):1157–1163

    PubMed  CAS  Google Scholar 

  10. Bizzaro N, Wiik A (2004) Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 22(3):349–355

    PubMed  CAS  Google Scholar 

  11. Anon. (2001) Guidelines and protocols advisory committee—antinuclear antibody (ANA) testing for connective tissue disease. http://www.bcguidelines.ca/guideline_ana_testing.html. Accessed June 4, 2012.

  12. Solomon DH, Kavanaugh AJ, Schur PH (2002) Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47(4):434–444

    Article  PubMed  Google Scholar 

  13. Avina-Zubieta JA, Sayre EC, Bernatsky S et al (2011) Adult Prevalence of Systemic Autoimmune Rheumatic Diseases (SARDs) in British Columbia. Can Arthritis Rheum 63(Suppl 10):1846

    Google Scholar 

  14. Anon. (2012) Population estimates, British Columbia and sub-provincial—BC stats. http://www.bcstats.gov.bc.ca/StatisticsBySubject/Demography/PopulationEstimates.aspx. Accessed May 21, 2012.

  15. Anon. (2012) Medical Services Plan home page. http://www.health.gov.bc.ca/msp/. Accessed July 24, 2012.

  16. Wiik AS (2005) Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 34(4):260–268

    Article  PubMed  CAS  Google Scholar 

  17. Dahle C, Skogh T, Aberg AK, Jalal A, Olcén P (2004) Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun 22(3):241–248

    Article  PubMed  CAS  Google Scholar 

  18. Peene I, Meheus L, Veys E, De Keyser F (2001) Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 60(12):1131–1136

    Article  PubMed  CAS  Google Scholar 

  19. Damoiseaux JGMC, Tervaert JWC (2006) From ANA to ENA: how to proceed? Autoimmun Rev 5(1):10–17

    Article  PubMed  CAS  Google Scholar 

  20. Fritzler MJ, Miller BJ (1995) Detection of autoantibodies to SS-A/Ro by indirect immunofluorescence using a transfected and overexpressed human 60 kD Ro autoantigen in HEp-2 cells. J Clin Lab Anal 9(3):218–224

    Article  PubMed  CAS  Google Scholar 

  21. Fritzler MJ, Wiik A, Fritzler ML, Barr SG (2003) The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 5(4):192–201

    Article  PubMed  CAS  Google Scholar 

  22. Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69(8):1420–1422

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the participants of the clinical consensus group for their contribution towards the direction of the study and development of the laboratory algorithm: Dr. Antonio Avina-Zubieta, Dr. Kenneth Blocka, Dr. David Ferguson, Dr. Bradley Fritz, Dr. Manstein Kan, Dr. Barry Koehler, Dr. Michael Moss, Dr. Michael Nimmo, Dr. Tom Perry, Dr. Ross Petty, Dr. Robert Schellenberg and Dr. Asa Wong.

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ada Man.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 58 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Man, A., Shojania, K., Phoon, C. et al. An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. Clin Rheumatol 32, 601–608 (2013). https://doi.org/10.1007/s10067-012-2141-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-2141-y

Keywords

Navigation